PDCD4
PDCD4 (programmed cell death 4, also known as H731) is an RNA-binding tumour suppressor that inhibits cap-dependent translation initiation. It acts through the helicase EIF4A1 and also modulates JUN kinase signalling. Browse Assay Genie's current range of PDCD4 research reagents below, or read on for the biology behind the target.
PDCD4 inhibits translation initiation and cap-dependent translation. It is thought to act by hindering the interaction between EIF4A1 and EIF4G, and it inhibits the helicase activity of EIF4A. The NCBI Gene summary describes the protein as binding to eukaryotic translation initiation factor 4A1 and blocking its function by preventing RNA binding. The protein itself also binds RNA.
Beyond translational control, PDCD4 modulates the activation of JUN kinase. It down-regulates expression of MAP4K1, which restrains MAPK85 activation and the consequent JUN-dependent transcription, events important in driving invasion. PDCD4 may also play a role in apoptosis. It is classed as a tumour suppressor and inhibits tumour promoter-induced neoplastic transformation, which is why researchers studying cancer biology and translation regulation often examine the PDCD4 protein.
The PDCD4 gene belongs to the HGNC group of microRNA protein coding host genes, and the protein belongs to the PDCD4 family. UniProt lists the protein in the nucleus and the cytoplasm. Alternative splicing of the gene produces multiple transcript variants. The previous HGNC name, programmed cell death 4 (neoplastic transformation inhibitor), reflects its role in suppressing transformation. Mouse and rat both have a Pdcd4 ortholog.
PDCD4 inhibits cap-dependent translation and the helicase activity of EIF4A, making it a useful subject for studying how initiation is regulated.
PDCD4 is a tumour suppressor that inhibits tumour promoter-induced neoplastic transformation, so it is studied in transformation and cancer research.
PDCD4 modulates JUN kinase activation and down-regulates MAP4K1, linking it to the JUN-dependent transcription that drives invasion.
PDCD4 may play a role in apoptosis and binds RNA, supporting work on cell death and RNA-protein interactions.
PDCD4 inhibits translation initiation and cap-dependent translation, probably by hindering the EIF4A1–EIF4G interaction and inhibiting EIF4A helicase activity. It also modulates JUN kinase activation, may play a role in apoptosis, and acts as a tumour suppressor that binds RNA.
PDCD4 is also known as H731. Its earlier HGNC name was programmed cell death 4 (neoplastic transformation inhibitor). UniProt names the protein programmed cell death protein 4. NCBI reports that alternative splicing of the gene gives multiple transcript variants.
Yes. The data list Pdcd4 orthologs in both mouse and rat. Researchers should check the datasheet of any product for its validated reactivity before using it in a given species.
Other programmed cell death family proteins that researchers often study alongside PDCD4.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q53EL6; product specifications from Assay Genie datasheets.